Andere Kunden interessierten sich auch für
![Untersuchung der L-Cystein-Biosynthese in Escherichia coli mit Techniken der Metabolom- und 13C-Stoffflussanalyse]( "Untersuchung der L-Cystein-Biosynthese in Escherichia coli mit Techniken der Metabolom- und 13C-Stoffflussanalyse")
Untersuchung der L-Cystein-Biosynthese in Escherichia coli mit Techniken der Metabolom- und 13C-Stoffflussanalyse32,90 €![Bactéria Escherichia coli DH1¿C31]( "Bactéria Escherichia coli DH1¿C31")
Bactéria Escherichia coli DH1¿C3123,99 €![Genes toxigénicos]( "Genes toxigénicos")
Genes toxigénicos "stx 1" y "stx 2" en aislados de Escherichia coli procedentes de excrementos de aves de corral locales29,99 €![Synthetic Metabolic Engineering of Corynebacterium glutamicum for Bio-based Production of 1,5-Diaminopentane]( "Synthetic Metabolic Engineering of Corynebacterium glutamicum for Bio-based Production of 1,5-Diaminopentane")
Synthetic Metabolic Engineering of Corynebacterium glutamicum for Bio-based Production of 1,5-Diaminopentane26,46 €![New Algorithms for Single Particle Cryo Electron Microscopic Image Processing]( "New Algorithms for Single Particle Cryo Electron Microscopic Image Processing")
New Algorithms for Single Particle Cryo Electron Microscopic Image Processing36,80 €![A multi-omics view on the pathogen Yersinia pseudotuberculosis ¿ bridging metabolism and virulence]( "A multi-omics view on the pathogen Yersinia pseudotuberculosis ¿ bridging metabolism and virulence")
A multi-omics view on the pathogen Yersinia pseudotuberculosis ¿ bridging metabolism and virulence29,15 €![From Waste to Value (Band 71). Bio-Nylon Monomers from Renewables using Corynebacterium glutamicum]( "From Waste to Value (Band 71). Bio-Nylon Monomers from Renewables using Corynebacterium glutamicum")
From Waste to Value (Band 71). Bio-Nylon Monomers from Renewables using Corynebacterium glutamicum23,55 €
Violacein and deoxyviolacein are promising therapeutics against pathogenic bacteria and viruses as well as tumor cells. In the present work, systems-wide metabolic engineering was applied to Escherichia coli for heterologous production of these high-value products. First, a high performance liquid chromatography method for accurate separation and quantification of violacein and deoxyviolacein was developed. Afterwards, a basic producer, E. coli dVio-1, that expressed the vioABCE cluster from Chromobacterium violaceum under control of the araBAD promoter and induction by L-arabinose, was constructed. Targeted intracellular metabolite analysis then identified bottlenecks in pathways that supply tryptophan, the major product building block of the natural products of interest. This was used for systems-wide engineering of serine, chorismate and tryptophan biosynthesis and the non-oxidative pentose-phosphate pathway, followed by elimination of L-arabinose catabolism. Transferred to a glycerol-based fed-batch process, E. coli dVio-8 surpassed the gram scale and produced 1.6 g L-1 deoxyviolacein (> 99.5% purity). The created chassis of a high-flux tryptophan pathway was complemented by genomic integration of the vioD gene of Janthinobacterium lividum, which enabled exclusive production of violacein (710 mg L-1 with 99.8% purity). This demonstrates the potential of E. coli as a platform for production of tryptophan based therapeutics.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.